Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes

International Journal of Pharmaceutics

Volumn 353, Issue 1-2, 2008, Pages 243-250

  Sun, Weitong ^a   Zhang, Na ^a   Li, Aiguo ^a   Zou, Weiwei ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bioavailability; Liposomes; N3 O toluyl fluorouracil (TFu); Prodrug

Indexed keywords

FLUOROURACIL; LIPOSOME; N3 O TOLUYLFLUOROURACIL; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENCAPSULATION; FILM; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; LIQUID LIQUID EXTRACTION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 40149098548     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.017     Document Type: Article

References (32)

1. A. Arien B. Dupuy Encapsulation of calcitonin in liposomes depends in the vesicle preparation method J. Microencapsul. 14 1997 753 760
2. K. Avgoustakis A. Beletsi Z. Panagi PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J. Control. Release 79 2002 123 135
3. M. Brandl D. Bachmann M. Drechsler K.H. Bauer Liposome preparation by a new high pressure homogenizer Gaul in Micron Lab 40 Drug Dev. Ind. Pharm. 16 1990 2167 2191
4. M. Brandl M. Drechsler D. Bachmann C. Tardi M. Schmidtgen K.H. Bauer Preparation and characterization of semi-solid phospholipid dispersions and dilutions thereof Int. J. Pharm. 170 1998 187 199
5. M. Cócera O. López J.L. Coderch Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: influence of the level of ceramides on this process J. Control. Release 68 2000 387 396
6. D.O. Corrigan A.M. Healy O.I. Corrigan The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials Int. J. Pharm. 262 2003 125 137
7. C. Dubernet Thermoananlysis of microspheres Thermochim. Acta 248 1995 259 269
8. M.S. El-Samaligy N.N. Afifi E.A. Mahmoud Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation Int. J. Pharm. 308 2006 140 148
9. R.M. Fielding Liposomal drug delivery: advantages and limitations from a clinical pharmacokinetic and therapeutic perspectives Clin. Pharmacokinet. 21 1991 155 164
10. R.J. Fraile L.H. Baker T.R. Buroker J. Horwitz V.K. Vaitkevicius Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion Cancer Res. 40 1980 2223 2228
11. M. Glavas-Dodov E. Fredro-Kumbaradzi K. Goracinova M. Simonoska S. Calis S. Trajkovic-Jolevska A.A. Hincal The effects of lyophilization on the stability of liposomes containing 5-FU Int. J. Pharm. 291 2005 79 86
12. G. Gregoriadis Liposome Technology 2nd ed. 1993 CRC Press Boca Raton, FL, US
13. I. Gutierro R.M. Hernandez M. Igartua Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77
14. D.Z. Hou C.S. Xie K.J. Huang C.H. Zhu The production and characteristics of solid lipid nanoparticles (SLNs) Biomaterials 24 2003 1781 1785
15. M.L. Immordino P. Brusa F. Rocco S. Arpicco M. Ceruti L. Cattel Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs J. Control. Release 100 2004 331 346
16. A.L. Klibanov L. Huang Long-circulating liposomes: development and perspectives Liposome Res. 2 1992 321 334
17. N.A. Kshirsagar S.K. Pandya G.B. Kirodian S. Sanath Liposomal drug delivery system from laboratory to clinic J. Postgrad. Med. 51 2005 5 15
18. Q. Li F.Y. Feng J. Han G.J. Sui Y.G. Zhu Y. Zhang Z.H. Zhang P.H. Wang M.Z. Zhou Y.C. Zhang Phase II clinical study of a new anticancer drug—Atofluding Chin. J. Cancer 20 2001 1387 1390
19. A. Lippacher R.H. Muller K. Mader Semisolid SLNTM dispersions for topical application: influence of formulation and production parameters on viscoelastic properties Eur. J. Pharm. Biopharm. 53 2002 155 160
20. 3- O -toluyl-flulorouracil Chin. Pharm. J. 37 2006 252 255
21. S.L. Morissettea O. Almarsson M.L. Peterson J.F. Remenar M.J. Read A.V. Lemmo S. Ellis M.J. Cima R.G. Colin High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids Adv. Drug Deliv. Rev. 56 2004 275 300
22. R.H. Muller K. Peters Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique Int. J. Pharm. 160 1998 229 237
23. E. Pupo A. Padron E. Santana J. Sotolongo D. Quintana S. Duenas C. Duarte M.C. de la Rosa E. Hardy Preparation of plasmid DNA-containing liposomes using a high-pressure homogenizationextrusion technique J. Control. Release 104 2005 379 396
24. W.T. Sun G.H. Huang J.S. Ye N. Zhang Determination encapsulation efficiencies of liposomes and nanoliposomes by protamine aggregation method Chin. Pharm. J. 41 2006 43 47
25. C.P. Tan M. Nakajima β-Carotene nanodispersions: preparation, characterizationand stability evaluation Food Chem. 92 2005 661 671
26. V.P. Torchilin T.S. Levchenko A.N. Lukyanov B.A. Khaw A.L. Klibanov R. Rammohan G.P. Samokhin K.R. Whiteman p -Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p -nitrophenylcarbonyl groups Biochim. Biophys. Acta 1511 2001 397 411
27. J.K. Vasir K. Tambwekar S. Garg Bioadhesive microspheres as a controlled drug delivery system Int. J. Pharm. 255 2003 13 32
28. V. Venhateswarlu K. Manjunath Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles J. Control. Release 95 2004 627 638
29. Yan, M.X., 2004. The synthesis and proclinical study of multiple-grade prodrugs of 5-fluorouracil. Shandong University post-graduate dissertation.
30. 1-stearyl-5-Fu and incorporation into solid lipid nanoparticles Arch. Pharm. Res. 6 2003 1096 1101
31. W.C. Zamboni Liposomal, nanoparticle, and conjugated formulations of anticancer agents Clin. Cancer Res. 11 2005 8230 8234
32. B. Zhao W.F. Xu Studies of 1-acetyl-3- O -toluyl-5-fluorouracil. I. Anti-tumor activity Acta Acad. Med. Shan Dong 24 1986 43 45